Literature DB >> 3653372

Glucocorticoid receptor in multiple myeloma.

T Murakami1, A Togawa, H Satch, M Katoh, Y Imamura, N Ohsawa, F Takaku.   

Abstract

Glucocorticoid receptor levels of myeloma cells were quantitated in 7 patients with multiple myeloma. In 4 patients, glucocorticoid receptor levels were less than 10 fmol/10(6) cells. In 3 patients, receptor levels were from 17.6 to 21.4 fmol/10(6) cells. We further examined the correlation between glucocorticoid receptor levels and effect of dexamethasone on 14C-thymidine incorporation and cell viability using 2 myeloma cell lines, OPM-1 and OPM-2, established from a patient with multiple myeloma. Glucocorticoid receptor levels of OPM-1 and OPM-2 were 8.5 fmol/10(6) cells and 63.2 fmol/10(6) cells, respectively. The sensitivity of OPM-1 to dexamethasone in these studies was lower than that of OPM-2. These results suggest the possibility that the low level of glucocorticoid receptor in myeloma cells may be important for predicting a poor response to glucocorticoid therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653372     DOI: 10.1111/j.1600-0609.1987.tb00164.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

1.  Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1.

Authors:  Christoph J Heuck; Jackie Szymonifka; Emily Hansen; John D Shaughnessy; Saad Z Usmani; Frits van Rhee; Elias Anaissie; Bijay Nair; Sarah Waheed; Yazan Alsayed; Nathan Petty; Clyde Bailey; Joshua Epstein; Antje Hoering; John Crowley; Bart Barlogie
Journal:  Clin Cancer Res       Date:  2012-08-01       Impact factor: 12.531

2.  Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group study.

Authors:  V Gupta; E B Thompson; D Stock-Novack; S E Salmon; H I Pierce; J D Bonnet; D Chilton; J Beckford
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.

Authors:  Charlotte Kervoëlen; Emmanuelle Ménoret; Patricia Gomez-Bougie; Régis Bataille; Catherine Godon; Séverine Marionneau-Lambot; Philippe Moreau; Catherine Pellat-Deceunynck; Martine Amiot
Journal:  Oncotarget       Date:  2015-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.